Brokerages Set Dyne Therapeutics, Inc. (NYSE:DYN) Price Target at $27.20

Dyne Therapeutics, Inc. (NYSE:DYN – Get Free Report) has received a consensus rating of “Buy” from the five ratings firms that are covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month price […]

Leave a Reply

Your email address will not be published.

Previous post UK mortgage approvals nosedive – Bank of England data
Next post Analysts Set Stantec Inc. (NYSE:STN) Target Price at $68.60